logo
Plus   Neg
Share
Email

Stock Alert: Astrotech Up 10%

Shares of Astrotech Corp. (ASTC) are gaining nearly 10% on Wednesday after the micro-cap company's subsidiary and Cleveland Clinic ink a deal for to develop a rapid COVID-19 breath test.

ASTC is currently trading at $2.3899, down $0.2099 or 9.6284%, on the Nasdaq.

Astrotech said its subsidiary BreathTech Corp. has inked a deal with the Cleveland Clinic Foundation. Under the deal, BreathTech's BreathTest-1000 will be used to compare exhaled breath from individuals who have tested positive on a COVID-19 polymerase chain reaction test with that from subjects who have had a negative COVID-19 PCR test.

The goal of the pilot study will be to analyze different volatile organic compounds from the breath to evaluate the correlation with different disease states.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Editors Pick
Nasdaq Inc. (NDAQ) reported Wednesday that its net income for the first quarter grew to $298 million or $1.78 per share from $203 million or $1.22 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $327 million or $1.96 per share, compared to $251 million... Guan's Mushroom Co. is recalling all cases of its 200g/7.05-ounce packages of Enoki Mushroom citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recalled Enoki is a product of China and comes in a clear plastic package with the description "Enoki Mushroom" in English, Korean and French, and Guan's logo in the front. Shares of Roche were gaining around 2 percent in Swiss trading after the drug major reported Wednesday a 3 percent rise in first-quarter sales at constant currency basis mainly driven by strong growth in Diagnostics Division. Sales, on a reported basis, edged down 1 percent mainly with significant impact from biosimilars. Looking ahead for fiscal 2021, the company continues to expect sales to grow
RELATED NEWS
Follow RTT